Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-4373
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis ; volume:36 ; number:6 ; day:11 ; month:1 ; year:2017 ; pages:1057-1062 ; date:6.2017
European journal of clinical microbiology & infectious diseases ; 36, Heft 6 (11.1.2017), 1057-1062, 6.2017
- Keyword
-
Pädiatrie
Kinderkrankheit
- Creator
-
Resch, B.
- Contributor
-
Bramreiter, V. S.
Kurath-Koller, S.
Freidl, T.
Urlesberger, B.
SpringerLink (Online service)
- DOI
-
10.1007/s10096-016-2891-6
- URN
-
urn:nbn:de:1111-201706023943
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Resch, B.
- Bramreiter, V. S.
- Kurath-Koller, S.
- Freidl, T.
- Urlesberger, B.
- SpringerLink (Online service)
Other Objects (12)
SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark
Risk prediction models of gestational diabetes mellitus before 16 gestational weeks
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study
Restricted Palivizumab Recommendations and the Impact on RSV Hospitalizations among Infants Born at > 29 Weeks of Gestational Age: An Italian Multicenter Study
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Thyroid dysfunction in preterm infants born before 32 gestational weeks
Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33–35 weeks of gestational age, based on data from the Spanish FLIP study
SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark
Risk prediction models of gestational diabetes mellitus before 16 gestational weeks
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study
Restricted Palivizumab Recommendations and the Impact on RSV Hospitalizations among Infants Born at > 29 Weeks of Gestational Age: An Italian Multicenter Study
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Thyroid dysfunction in preterm infants born before 32 gestational weeks
Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33–35 weeks of gestational age, based on data from the Spanish FLIP study
SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark
Risk prediction models of gestational diabetes mellitus before 16 gestational weeks
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study
Restricted Palivizumab Recommendations and the Impact on RSV Hospitalizations among Infants Born at > 29 Weeks of Gestational Age: An Italian Multicenter Study
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Thyroid dysfunction in preterm infants born before 32 gestational weeks
Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)